Pharmacological and Non-Pharmacological Treatment in Non-Alcoholic Fatty Liver Disease

Medicine & Life Sciences

• Alcohols 11%
• Fat-Restricted Diet 19%
• Fatty Liver 33%
• Fibrosis 11%
• Hepatocytes 26%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 15%
• Incidence 7%
• Indonesia 18%
• Inflammation 18%
• Insulin 10%
• Insulin Resistance 25%
• Life Style 12%
• Liver Cirrhosis 14%
• Liver Diseases 13%
• Losartan 18%
• Metformin 16%
• Non-alcoholic Fatty Liver Disease 100%
• Nonesterified Fatty Acids 16%
• Orlistat 22%
• Oxidative Stress 11%
• Pharmacology 61%
• Sugars 15%
• Therapeutics 15%
• Thiazolidinediones 20%
• Ursodeoxycholic Acid 20%
• Vitamin E 16%